---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-006219"
form_type: "8-K"
ticker: "TLSI"
cik: "0001826667"
company_name: "TriSalus Life Sciences, Inc."
filed_at: "2026-02-09T23:59:59+00:00"
generated_at: "2026-05-16T03:55:58.797195+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# TriSalus Life Sciences appoints Michael Stansky to board, replacing Dr. Desai

## Summary
- Dr. Arjun "JJ" Desai resigned from the board on February 3, 2026; no disagreement with the company.
- Michael P. Stansky appointed to the board effective February 4, 2026.
- Stansky brings 40 years of investment management and healthcare experience; former Managing Director at Tudor Investment Corp.
- He will serve on the Audit, Compensation, and Science and Technology Committees.
- Stansky currently serves on boards of Insightec and Momentis Surgical; past boards include Mako Surgical and Transmedics.

## SEC filing metadata
- accession: 0001628280-26-006219
- form_type: 8-K
- ticker: TLSI
- cik: 0001826667
- company_name: TriSalus Life Sciences, Inc.
- filed_at: 2026-02-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826667/000162828026006219/0001628280-26-006219-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826667/000162828026006219/tlsi-20260203.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-006219
- JSON: https://secwatch.observer/filing/0001628280-26-006219.json
- Plain text: https://secwatch.observer/filing/0001628280-26-006219.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.